Stifel Affirms Buy Rating on Illumina (ILMN) Stock
Analysts at Stifel are bullish about Illumina, Inc.’s (NASDAQ:ILMN) prospects despite the stock capitulating 36% year to date.
Illumina Inc. (ILMN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Corvex Capital Keith Meister | 3,829,608 | $303,841,099 | +126% | 11.5% |
| 2. | Point State Capital Zach Schreiber | 2,516,827 | $199,685,054 | +57% | 2.89% |
| 3. | AQR Capital Management Cliff Asness | 2,121,585 | $165,483,616 | +362% | 0.17% |
| 4. | GuardCap Asset Management Guardian Capital | 2,071,095 | $164,320,677 | -14% | 3.18% |
| 5. | Rima Senvest Management Richard Mashaal | 1,151,292 | $91,343,507 | +8% | 3.82% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $81.21 | 6,100 | Officer | 24,906 | 2025-05-12 | Filing | |
| $82.26 | 100 | Officer, Director | 83,390 | 2025-05-13 | Filing | |
| $81.56 | 804 | Officer, Director | 83,290 | 2025-05-13 | Filing | |
| $80.70 | 4,946 | Officer, Director | 82,486 | 2025-05-13 | Filing | |
| $82.66 | 200 | Officer, Director | 77,540 | 2025-05-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $112.84 | 315 | Officer | 8,314 | 2023-11-07 | Filing | |
| $167.04 | 500 | Officer | 45,524 | 2023-08-22 | Filing | |
| $190.08 | 500 | Officer | 46,022 | 2023-07-24 | Filing | |
| $200.00 | 500 | Officer | 46,522 | 2023-06-22 | Filing | |
| $209.67 | 1,676 | Officer | 47,022 | 2023-05-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 18,899,411 | $1,499,482,664 | 0.24% | |
| 2. | 18,737,109 | $1,486,602,239 | 0.03% | |
| 3. | 16,371,662 | $1,298,927,663 | 0.02% | |
| 4. | 5,851,870 | $464,287,366 | 0.02% | |
| 5. | 4,179,011 | $334,320,880 | 0.86% |
News See All
15 Small-Cap Healthcare Stocks Hedge Funds Are Buying
The U.S. healthcare sector has performed better in 2025 compared to the broader market. After two years of weak performance, the healthcare sector kicked off on a strong note in 2025.
Illumina, Inc. (NASDAQ:ILMN) Q1 2025 Earnings Call Transcript
Operator: Good day ladies and gentlemen, and welcome to the First Quarter 2025 Illumina Earnings Conference Call. At this time, all participants are in a listen only mode.
Here’s Why Artisan Mid Cap Fund Decided to Exit Illumina (ILMN)
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Should You Hold Illumina (ILMN)?
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
15 Recent Activist Investor Campaigns
Economic uncertainty and market volatility are some of the factors fueling activist investor campaigns in 2025.
12 Best Diagnostics Stocks to Invest In Right Now
According to a report by Mordor Intelligence, the clinical diagnostics market has a size of $88.79 billion as of 2025.
15 Best Biotech Stocks to Buy According to Billionaires
Although biotech stocks had a "challenging" year in 2024, JPMorgan believes that some of the industry's companies could see significant growth in the months to come.
Jim Cramer’s Latest Lightning Round: 7 Stocks in Focus
On Thursday, Jim Cramer, the host of Mad Money, pointed out that the ongoing fears surrounding President Donald Trump's aggressive tariff policies continued to impact the market.
Why These 15 Large-Cap Stocks Are Plunging So Far In 2025
The big and large-cap stocks have spearheaded the rally in the past two years, but Wall Street’s expectations have gotten ahead of many of their fundamentals.
Billionaire Hedge Funds
